List of works - Sonia Fargue

A mutation creating an out-of-frame alternative translation initiation site in the GRHPR 5'UTR causing primary hyperoxaluria type II.

scientific article published on 19 November 2014

Bone metabolism in oxalosis: a single-center study using new imaging techniques and biomarkers

scientific article published on 6 March 2010

Development of a phenotypic high-content assay to identify pharmacoperone drugs for the treatment of primary hyperoxaluria type 1 by high-throughput screening

scientific article published on January 2015

Disease recurrence in paediatric renal transplantation

scientific article

Effects of alanine:glyoxylate aminotransferase variants and pyridoxine sensitivity on oxalate metabolism in a cell-based cytotoxicity assay.

scientific article published on 5 February 2016

Endpoints for Clinical Trials in Primary Hyperoxaluria

scientific article published on 12 March 2020

Factors influencing clinical outcome in patients with primary hyperoxaluria type 1

scientific article published on 01 December 2014

Four of the most common mutations in primary hyperoxaluria type 1 unmask the cryptic mitochondrial targeting sequence of alanine:glyoxylate aminotransferase encoded by the polymorphic minor allele

scientific article published on 10 December 2012

Genotype-phenotype correlation in primary hyperoxaluria type 1: the p.Gly170Arg AGXT mutation is associated with a better outcome

scientific article published on 16 December 2009

Hyperoxalurie primitive

scientific article published on 02 June 2011

Hyperuricemia after liver transplantation in children

scientific article published on 4 June 2008

Metabolism of (13)C5-hydroxyproline in mouse models of Primary Hyperoxaluria and its inhibition by RNAi therapeutics targeting liver glycolate oxidase and hydroxyproline dehydrogenase

scientific article published on 2 December 2015

Multiple mechanisms of action of pyridoxine in primary hyperoxaluria type 1.

scientific article published on 15 April 2013

New treatment strategies for proliferative lupus nephritis: keep children in mind!

scientific article published on January 2007

Pharmacologic rescue of an enzyme-trafficking defect in primary hyperoxaluria 1.

scientific article

Primary hyperoxaluria

scientific article

Primary hyperoxaluria type 1: still challenging!

scientific article published on 30 June 2006

Primary hyperoxaluria type 1: strategy for organ transplantation

scientific article published on October 2010

Pyridoxamine and pyridoxal are more effective than pyridoxine in rescuing folding-defective variants of human alanine:glyoxylate aminotransferase causing primary hyperoxaluria type I.

scientific article published on 21 July 2015

Screening for NPHS2 mutations may help predict FSGS recurrence after transplantation

scientific article

Survey of first-year medical students to assess their knowledge and attitudes toward organ transplantation and donation.

scientific article

Tacrolimus nephrotoxicity: beware of the association of diarrhea, drug interaction and pharmacogenetics

scientific article published on 21 January 2010

The N-terminal extension is essential for the formation of the active dimeric structure of liver peroxisomal alanine:glyoxylate aminotransferase

scientific article

List of works by Sonia Fargue

A mutation creating an out-of-frame alternative translation initiation site in the GRHPR 5'UTR causing primary hyperoxaluria type II.

Bone metabolism in oxalosis: a single-center study using new imaging techniques and biomarkers

Development of a phenotypic high-content assay to identify pharmacoperone drugs for the treatment of primary hyperoxaluria type 1 by high-throughput screening

Disease recurrence in paediatric renal transplantation

Effects of alanine:glyoxylate aminotransferase variants and pyridoxine sensitivity on oxalate metabolism in a cell-based cytotoxicity assay.

Endpoints for Clinical Trials in Primary Hyperoxaluria

Factors influencing clinical outcome in patients with primary hyperoxaluria type 1

Four of the most common mutations in primary hyperoxaluria type 1 unmask the cryptic mitochondrial targeting sequence of alanine:glyoxylate aminotransferase encoded by the polymorphic minor allele

Genotype-phenotype correlation in primary hyperoxaluria type 1: the p.Gly170Arg AGXT mutation is associated with a better outcome

Hyperoxalurie primitive

Hyperuricemia after liver transplantation in children

Metabolism of (13)C5-hydroxyproline in mouse models of Primary Hyperoxaluria and its inhibition by RNAi therapeutics targeting liver glycolate oxidase and hydroxyproline dehydrogenase

Multiple mechanisms of action of pyridoxine in primary hyperoxaluria type 1.

New treatment strategies for proliferative lupus nephritis: keep children in mind!

Pharmacologic rescue of an enzyme-trafficking defect in primary hyperoxaluria 1.

Primary hyperoxaluria

Primary hyperoxaluria type 1: still challenging!

Primary hyperoxaluria type 1: strategy for organ transplantation

Pyridoxamine and pyridoxal are more effective than pyridoxine in rescuing folding-defective variants of human alanine:glyoxylate aminotransferase causing primary hyperoxaluria type I.

Screening for NPHS2 mutations may help predict FSGS recurrence after transplantation

Survey of first-year medical students to assess their knowledge and attitudes toward organ transplantation and donation.

Tacrolimus nephrotoxicity: beware of the association of diarrhea, drug interaction and pharmacogenetics

The N-terminal extension is essential for the formation of the active dimeric structure of liver peroxisomal alanine:glyoxylate aminotransferase